Search Within

Christian Grommes

Formats
  1. Meeting Abstract (81)
  2. Journal Article (50)
  3. Review (14)
  4. Book Section (2)
  5. Research Letter (2)
  6. Correspondence (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (58)
  2. GSK Faculty (47)
  3. Human Oncology and Pathogenesis Program (41)
  4. Radiology, Department of (40)
  5. Department of Medicine (36)
  6. Neuroradiology Service (36)

More Groups

People
  1. Lisa De Angelis (46)
  2. Ingo Mellinghoff (39)
  3. Lauren Schaff (37)
  4. Elena Pentsova (33)
  5. Thomas Kaley (30)
  6. Igor Gavrilovic (28)

More People

Years
  1. 2025 (4)
  2. 2024 (16)
  3. 2023 (20)
  4. 2022 (20)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. Neuro-Oncology (38)
  2. Blood (21)
  3. Journal of Clinical Oncology (14)
  4. Leukemia and Lymphoma (6)
  5. Hematological Oncology (5)
  6. International Journal of Radiation Oncology, Biology, Physics (5)

More Publications

Publishers
  1. Oxford University Press (44)
  2. American Society of Hematology (22)
  3. American Society of Clinical Oncology (18)
  4. Springer (10)
  5. Elsevier Inc. (9)
  6. Taylor & Francis Group (9)

More Publishers

Results (153)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Central nervous system lymphoma: Approach to diagnosis and treatment
    Review

    Correia, C. E.; Schaff, L. R.; Grommes, C.
    The Cancer Journal (2020)

    Fulltext@MSK | Save
  • Primary CNS lymphoma: Current concepts and therapeutic perspectives
    Meeting Abstract

    Grommes, C.
    Neuro-Oncology Advances (2019)

    Fulltext@MSK | Save
  • Increased number of high dose methotrexate cycles and the addition of rituximab is associated with better outcomes in a large primary CNSL cohort
    Meeting Abstract

    Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A.; Panageas, K.; Grommes, C.
    Blood (2019)

    Fulltext@MSK | Save
  • Phase Ib of copanlisib in combination with ibrutinib in recurrent/refractory primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Grommes, C.; Gavrilovic, I.; Miller, A. M.; Stone, J. B.; Kaley, T.; Madzsar, J. T.; Schumpp, A.; Butler, B. T.; Schaff, L.; Mellinghoff, I. K.
    Blood (2019)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, BCNU, etoposide, and prednisone (RMBVP) for the treatment of relapsed/recurrent primary central nervous system lymphoma: A retrospective single center study
    Meeting Abstract

    Reiss, S.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ib study of proton craniospinal irradiation for the treatment of solid tumor leptomeningeal metastases
    Meeting Abstract

    Yang, T. J.; Wolden, S.; Yamada, J.; Mehallow, M.; Skakodub, A.; Young, R.; Gavrilovic, I.; Lin, A.; Santomasso, B.; Grommes, C.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Molecular profiling of primary central nervous system lymphomas - Predictive and prognostic value?
    Review

    Ho, K. G.; Grommes, C.
    Current Opinion in Neurology (2019)

    Fulltext@MSK | Save
  • Prognostic value of FDG-PET/CT in recurrent/refractory CNS lymphoma receiving Ibrutinib-based therapies
    Meeting Abstract

    Krebs, S.; Wolfe, J.; Mellinghoff, I.; Grommes, C.; Schoder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions
    Journal Article

    Malani, R.; Bhatia, A.; Wolfe, J.; Grommes, C.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
    Journal Article

    Jonsson, P.; Lin, A. L.; Young, R. J.; DiStefano, N. M.; Hyman, D. M.; Li, B. T.; Berger, M. F.; Zehir, A.; Ladanyi, M.; Solit, D. B.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save